Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Abrocitinib may effectively treat Lichen Planopilaris.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Modern treatments can effectively regrow hair and improve life for people with alopecia areata.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

CS12192 effectively treats alopecia areata with better safety than current options.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.